Home Ingredients VitAlign® (plant polyphenol cellular-vitality blend — FutureCeuticals)
Antioxidant

VitAlign® (plant polyphenol cellular-vitality blend — FutureCeuticals)

Evidence Level
Preliminary
2 Clinical Trials
4 Documented Benefits
1/5 Evidence Score

VitAlign is a branded, low-dose polyphenol blend from FutureCeuticals built from seven plant extracts and powders (blueberry, broccoli, cherry, green coffee bean, green tea, kale and turmeric). It is standardized to at least 60% total polyphenols, 30% catechins and 3% curcuminoids, delivering catechins, chlorogenic acids, EGCG and curcumin in a single 50 mg serving. In one small manufacturer-funded study, a single 50 mg dose lowered several blood markers of reactive oxygen species and raised a nitric oxide marker (NOHb). These are short-term laboratory markers measured over three hours. No clinical antioxidant, immune, or cardiovascular outcome has been measured in people.

Studied Dose Single 50 mg oral dose; 50 mg/day (90-day metabolic study is manufacturer data)
Active Compound Blend of 7 plant extracts standardized to ~60% polyphenols, 30% catechins, 3% curcuminoids

Benefits

Broad-spectrum antioxidant support

VitAlign supplies concentrated plant polyphenols, catechins and curcuminoids that help the body manage excess reactive oxygen species. In a single-dose human study it lowered ROS from mitochondrial and enzyme-driven sources, supporting the cell's own antioxidant balance.

Supported by Trial 1, Trial 2

Effect on immune-related oxidative markers

In a single-dose study of 28 adults recovering from a moderate case of COVID-19, the blend lowered NOX2- and iNOS-related reactive oxygen species markers and shifted several inflammatory and immune markers measured in blood. These are laboratory markers only. Whether the blend changes how often people get sick or how quickly they recover has not been measured.

Supported by Trial 1

Raised a nitric oxide marker in one acute study

In this single acute-dose study a 50 mg dose raised a circulating nitric oxide marker (NOHb) by about 33% over three hours. This is a blood marker, not a measured change in blood pressure, blood-vessel function, or any cardiovascular outcome.

Supported by Trial 1

Cellular and mitochondrial vitality

In laboratory terms the polyphenol blend targets reactive oxygen species generated inside mitochondria. Effects on cellular energy or aging have not been measured in people; the only human data are blood markers from a single study.

Supported by Trial 1

Mechanism of action

1

Multi-pathway ROS regulation

The blend's polyphenols, catechins (including EGCG) and curcuminoids scavenge and modulate reactive oxygen species from several sources at once, including mitochondrial ROS and enzymatic ROS produced by NADPH oxidase 2 (NOX2) and inducible nitric oxide synthase (iNOS).

2

Nitric oxide preservation

By limiting superoxide-driven quenching of nitric oxide, the blend was associated with higher circulating nitric-oxide hemoglobin (NOHb), which can support endothelial signaling and healthy vasodilation.

3

Polyphenol redox and enzyme modulation

Constituent compounds such as EGCG, chlorogenic acids and curcumin act as direct radical scavengers and can influence redox-sensitive signaling and antioxidant enzyme activity, the proposed basis for the observed broad-spectrum activity at a low dose.

Clinical trials

1
Single-dose plant polyphenol blend vs high-dose vitamin C after viral infection
PubMed

Randomized, double-blind human study of the vitAlign blend, published under the label 'PB-Blend', as a single 50 mg dose versus 1000 mg vitamin C (Fink et al., 2025, International Journal of Molecular Sciences). Note: the study was funded by the manufacturer (VDF FutureCeuticals) and used ex vivo blood biomarkers, not clinical disease endpoints.

28 medically stable adults aged 40-55 recovering from a moderate course of COVID-19 (18-24 days post-positive PCR)

A single 50 mg dose significantly reduced mitochondrial ROS (~56%), iNOS-dependent ROS (~60%) and NOX2-dependent ROS (~49%), and raised circulating nitric-oxide hemoglobin (~33%). A 20x-larger 1000 mg vitamin C control affected only NOX2 ROS and did not raise nitric oxide. Small, acute, single-dose study; effects on longer-term clinical outcomes were not measured.

2
90-day mitochondrial ROS marker reduction (manufacturer-reported, not independently published)

Manufacturer-reported study; not located as a peer-reviewed PubMed publication at time of writing

Adults described by FutureCeuticals as being in a compromised metabolic state

FutureCeuticals reports that 50 mg/day of VitAlign over 90 days significantly reduced mitochondrial ROS generation. Treated as manufacturer data pending independent publication.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated in the small short-term study; long-term safety data are limited
Contains turmeric/curcumin, which may cause mild stomach upset or nausea in sensitive individuals
Green tea and green coffee components contribute a small amount of caffeine (about 1.7 mg per 50 mg dose), which is very low but worth noting for highly caffeine-sensitive people
Possible allergy in people sensitive to any of the source plants (blueberry, cherry, broccoli, kale, green coffee, green tea, turmeric)

Important Drug interactions

Blood thinners and antiplatelet drugs (e.g., warfarin, aspirin, clopidogrel): turmeric/curcumin and polyphenols may add to bleeding risk; tell your doctor before combining
Blood-pressure medications: nitric-oxide-supporting polyphenols could in theory add to blood-pressure lowering; discuss with your doctor if you take antihypertensives
Antidiabetic medications: green coffee chlorogenic acids and green tea catechins may influence blood sugar; monitor and tell your doctor
As with any supplement, tell your doctor or pharmacist about VitAlign before surgery or if you take prescription medication

Featured in these supplement guides

Circulation & Varicose Veins→Inflammation→

More Antioxidant Ingredients

Antioxidant
Green Tea
Green tea comes from the leaves of Camellia sinensis and is rich in catechins, especially…
Antioxidant
Lutein
Lutein is a yellow carotenoid that collects in the retina, where, together with zeaxanthin…
Antioxidant
Curcumin/Turmeric
Curcumin, the main bioactive compound in turmeric (Curcuma longa), is usually taken as a s…
Antioxidant
NAC (N-Acetylcysteine)
N-acetylcysteine (NAC) is a modified form of the amino acid cysteine. The body uses cystei…

Explore Other Ingredients

Athletic Performance
Nitrosigine® (Arginine Silicate)
Nitrosigine® (Nutrition 21) is a patented, inositol-stabilized arginine silicate complex e…
Energy
Vitamin B12
Vitamin B12 (cobalamin) is a water-soluble vitamin needed for red blood cell formation, DN…
Athletic Performance
L-Citrulline
L-Citrulline is a naturally occurring amino acid that supports nitric oxide production, he…

Frequently asked questions about VitAlign® (plant polyphenol cellular-vitality blend — FutureCeuticals)

What is VitAlign?

VitAlign is a branded, low-dose polyphenol blend from FutureCeuticals built from seven plant extracts and powders (blueberry, broccoli, cherry, green coffee bean, green tea, kale and turmeric).

What is VitAlign used for?

VitAlign is researched primarily for Antioxidant. VitAlign supplies concentrated plant polyphenols, catechins and curcuminoids that help the body manage excess reactive oxygen species.

What is the recommended dosage of VitAlign?

The clinically studied dose is Single 50 mg oral dose; 50 mg/day (90-day metabolic study is manufacturer data) Always follow the product label and check with a healthcare provider for personal advice.

Is VitAlign safe, and does it have side effects?

For most healthy adults, VitAlign is well tolerated at studied doses. Reported effects can include: Generally well tolerated in the small short-term study; long-term safety data are limited Contains turmeric/curcumin, which may cause mild stomach upset or nausea in sensitive individuals It may also interact with some medications. VitAlign is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does VitAlign interact with any medications?

Possible interactions include: Blood thinners and antiplatelet drugs (e.g., warfarin, aspirin, clopidogrel): turmeric/curcumin and polyphenols may add to bleeding risk; tell your doctor before combining Blood-pressure medications: nitric-oxide-supporting polyphenols could in theory add to blood-pressure loweri… If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for VitAlign?

NutraSmarts rates the evidence for VitAlign as Preliminary (1 out of 5). It is backed by 2 clinical trials and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Fink B, Hunter JM, Pietrzkowski Z, Fink R, Brunssen C, Morawietz H, Nemzer B A Plant-Based Dietary Supplement Exhibits Significant Effects on Markers of Oxidative Stress, Inflammation, and Immune Response in Subjects Recovering from Respiratory Viral Infection: A Randomized, Double-Blind Clinical Study Using Vitamin C as a Positive Control International Journal of Molecular Sciences. 2025;Int J Mol Sci. 2025 May 29;26(11):5209.PubMedUsed to support: In 28 adults recovering from a moderate case of COVID-19, a single 50 mg dose reduced ex vivo markers of mitochondrial (up to about 56%), iNOS (up to about 60%) and NOX2 (up to about 49%) reactive oxygen species and raised a circulating nitric oxide marker (NOHb, about 33%) over three hours, while a 1000 mg vitamin C control affected only NOX2 markers. All outcomes were short-term blood and cell markers, not clinical antioxidant, immune, or cardiovascular outcomes. The study was funded by the manufacturer (VDF FutureCeuticals) and several authors are company employees.